Skip to main content
. 2018 Apr 21;12(4):880–889. doi: 10.1177/1932296818769933

Table 3.

Studies of Patients Started on CSII in the Hospital.

Study Diabetes type Population Pump vendor Sample size Type of study Outcome measurement
Bodur et al13 Both MICU Deltec Cozmo 60 patients; randomized to CSII or IV insulin infusion Randomized Controlled Study Mean blood glucose level
Hypoglycemic events
Lee et al14 Type 2 General inpatient Medtronic 27 patients- (8 CSII, 10 CIII, 9 conventional) Prospective randomized study Mean glucose levels
Fasting glucose levels
Safety
Patient satisfaction
Kannampilly15 Type 2 General inpatient Medtronic 4 patients Case Series Fasting and postprandial CBG
A1c
Safety
Levitt et al16 Type 2 General inpatient OmniPod Total 16 patients in 3 groups according to CSII use and CGMS assignment Randomized prospective; subjects in two groups blinded to CGMS data Mean capillary glucose
Hypoglycemia frequency
Time in target.

MICU: Medical intensive care unit. CIII: Continuous intravenous insulin infusion. CSII: Continuous Subcutaneous insulin infusion. CBG: Capillary blood glucose. Continuous glucose monitoring system.